Advances in cellular reprograming have shown that the delivery of specific transcription factors can result in the shift of one cell type to another. Brief forced expression of the four Yamanaka reprogramming factors (Klf4, Sox2, c-Myc, and Oct4) is able to convert many cell types into induced pluripotent stem cells, whereas some lineage specific transcription factors can convert cells from one type directly to another. Numerous strategies have already been developed for deriving neural cell types, with the hopes of better understanding/alleviating neurodegenerative disease. These cells facilitate drug discovery and constitute an autologous source of cells for brain repair, thus, avoiding rejection issues faced by allografts derived from embryonic stem cells. However, proper characterization of the various types of reprogrammed cells and an understanding of how these cells acquire neural fate is necessary before their translation into the clinic. Here, we review the progress, problems, and prospects with reprogrammed cell types with regards to neurodegenerative disease.
AddisRCHsuFCWrightRLDichterMACoulterDAGearhartJD. 2011. Efficient conversion of astrocytes to functional midbrain dopaminergic neurons using a single polycistronic vector. PLoS One6(12):e28719.
2.
AmpsKAndrewsPWAnyfantisGArmstrongLAverySBaharvandH, and others. 2011. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol29(12):1132–44.
3.
AnMCZhangNScottGMontoroDWittkopTMooneyS, and others. 2012. Genetic correction of Huntington’s disease phenotypes in induced pluripotent stem cells. Cell Stem Cell11(2):253–63.
4.
AnderssonETryggvasonUDengQFrilingSAlekseenkoZRobertB, and others. 2006. Identification of intrinsic determinants of midbrain dopamine neurons. Cell124(2):393–405.
5.
BainGKitchensDYaoMHuettnerJEGottliebDI. 1995. Embryonic stem cells express neuronal properties in vitro. Dev Biol168(2):342–57.
6.
BakerDEHarrisonNJMaltbyESmithKMooreHDShawPJ, and others. 2007. Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat Biotechnol25(2):207–15.
7.
BellinMMarchettoMCGageFHMummeryCL. 2012. Induced pluripotent stem cells: the new patient?Nat Rev Mol Cell Biol13(11):713–26.
8.
BlauHMChiuCPWebsterC. 1983. Cytoplasmic activation of human nuclear genes in stable heterocaryons. Cell32(4):1171–80.
9.
BlauHMPavlathGKHardemanECChiuCPSilbersteinLWebsterSG, and others. 1985. Plasticity of the differentiated state. Science230(4727):758–66.
10.
BoultingGLKiskinisECroftGFAmorosoMWOakleyDHWaingerBJ, and others. 2011. A functionally characterized test set of human induced pluripotent stem cells. Nat Biotechnol29(3):279–86.
11.
CaiazzoMDell’AnnoMTDvoretskovaELazarevicDTavernaSLeoD, and others. 2011. Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature476(7359):224–7.
12.
CamnasioSCarriADLombardoAGradIMariottiCCastucciA, and others. 2012. The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington’s disease patients demonstrates mutation related enhanced lysosomal activity. Neurobiol Dis46(1):41–51.
13.
ChenSXuYChenYLiXMouWWangL, and others. 2012. SOX2 gene regulates the transcriptional network of oncogenes and affects tumorigenesis of human lung cancer cells. PLoS One7(5):e36326.
14.
ChinMHMasonMJXieWVoliniaSSingerMPetersonC, and others. 2009. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell5(1):111–23.
15.
CooperOSeoHAndrabiSGuardia-LaguartaCGraziottoJSundbergM, and others. 2012. Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson’s disease. Sci Transl Med4(141):141ra90.
16.
DimosJTRodolfaKTNiakanKKWeisenthalLMMitsumotoHChungW, and others. 2008. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science321(5893):1218–21.
17.
DoetschF. 2003. The glial identity of neural stem cells. Nat Neurosci6(11):1127–34.
18.
EbertADYuJRoseFFJrMattisVBLorsonCLThomsonJA, and others. 2009. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature457(7227):277–80.
19.
EfeJAHilcoveSKimJZhouHOuyangKWangG, and others. 2011. Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nat Cell Biol13(3):215–22.
20.
EgawaNKitaokaSTsukitaKNaitohMTakahashiKYamamotoT, and others. 2012. Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci Transl Med4(145):145ra104.
21.
FreemanMR. 2010. Specification and morphogenesis of astrocytes. Science330(6005):774–8.
22.
FusakiNBanHNishiyamaASaekiKHasegawaM. 2009. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci85(8):348–62.
23.
GaspardNBouschetTHerpoelANaeijeGvan den AmeeleJVanderhaeghenP. 2009. Generation of cortical neurons from mouse embryonic stem cells. Nat Protoc4(10):1454–63.
24.
GaspardNBouschetTHourezRDimidschsteinJNaeijeGvan den AmeeleJ, and others. 2008. An intrinsic mechanism of corticogenesis from embryonic stem cells. Nature455(7211):351–7.
25.
GonzalezFBoueSIzpisua BelmonteJC. 2011. Methods for making induced pluripotent stem cells: reprogramming a la carte. Nat Rev Genet12(4):231–42.
26.
GoreALiZFungHLYoungJEAgarwalSAntosiewicz-BourgetJ, and others. 2011. Somatic coding mutations in human induced pluripotent stem cells. Nature471(7336):63–7.
27.
GrskovicMJavaherianAStruloviciBDaleyGQ. 2011. Induced pluripotent stem cells—opportunities for disease modelling and drug discovery. Nat Rev Drug Discov10(12):915–29.
28.
GurdonJB. 1962. Adult frogs derived from the nuclei of single somatic cells. Dev Biol4:256–73.
29.
HargusGCooperODeleidiMLevyALeeKMarlowE, and others. 2010. Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc Natl Acad Sci U S A107(36):15921–6.
30.
HeinrichCBlumRGasconSMasserdottiGTripathiPSanchezR, and others. 2010. Directing astroglia from the cerebral cortex into subtype specific functional neurons. PLoS Biol8(5):e1000373.
31.
HochstimCDeneenBLukaszewiczAZhouQAndersonDJ. 2008. Identification of positionally distinct astrocyte subtypes whose identities are specified by a homeodomain code. Cell133(3):510–22.
32.
HockemeyerDWangHKianiSLaiCSGaoQCassadyJP, and others. 2011. Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol. 29(8):731–4.
33.
HuBYWeickJPYuJMaLXZhangXQThomsonJA, and others. 2010. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci U S A107(9):4335–40.
34.
HusseinSMBatadaNNVuoristoSChingRWAutioRNarvaE, and others. 2011. Copy number variation and selection during reprogramming to pluripotency. Nature471(7336):58–62.
35.
HusseinSMElbazJNagyAA. 2013. Genome damage in induced pluripotent stem cells: Assessing the mechanisms and their consequences. Bioessays35(3):152–62.
36.
IsraelMAYuanSHBardyCReynaSMMuYHerreraC, and others. 2012. Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells. Nature482(7384):216–20.
37.
KarowMSanchezRSchichorCMasserdottiGOrtegaFHeinrichC, and others. 2012. Reprogramming of pericyte-derived cells of the adult human brain into induced neuronal cells. Cell Stem Cell11(4):471–6.
38.
KawasakiHMizusekiKNishikawaSKanekoSKuwanaYNakanishiS, and others. 2000. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron28(1):31–40.
39.
KimJEfeJAZhuSTalantovaMYuanXWangS, and others. 2011a. Direct reprogramming of mouse fibroblasts to neural progenitors. Proc Natl Acad Sci U S A108(19):7838–43.
40.
KimJSuSCWangHChengAWCassadyJPLodatoMA, and others. 2011b. Functional integration of dopaminergic neurons directly converted from mouse fibroblasts. Cell Stem Cell9(5):413–9.
41.
KriksSShimJWPiaoJGanatYMWakemanDRXieZ, and others. 2011. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s disease. Nature480(7378):547–51.
42.
KumarSMLiuSLuHZhangHZhangPJGimottyPA, and others. 2012. Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation. Oncogene31(47):4898–911.
43.
LaurentLCUlitskyISlavinITranHSchorkAMoreyR, and others. 2011. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell8(1):106–18.
44.
LeeGPapapetrouEPKimHChambersSMTomishimaMJFasanoCA, and others. 2009. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature461(7262):402–6.
45.
LujanEChandaSAhleniusHSudhofTCWernigM. 2012. Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells. Proc Natl Acad Sci U S A109(7):2527–32.
46.
MaysharYBen-DavidULavonNBiancottiJCYakirBClarkAT, and others. 2010. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell7(4):521–31.
47.
MeissnerAWernigMJaenischR. 2007. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol25(10):1177–81.
48.
NarvaEAutioRRahkonenNKongLHarrisonNKitsbergD, and others. 2010. High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat Biotechnol28(4):371–7.
49.
Nowak-ImialekMNiemannH. 2012. Pluripotent cells in farm animals: state of the art and future perspectives. Reprod Fertil Dev25(1):103–28.
50.
PapadeasSTMaragakisNJ. 2009. Advances in stem cell research for amyotrophic lateral sclerosis. Curr Opin Biotechnol20(5):545–51.
51.
ParkIHAroraNHuoHMaheraliNAhfeldtTShimamuraA, and others. 2008. Disease-specific induced pluripotent stem cells. Cell134(5):877–86.
52.
PerrierALTabarVBarberiTRubioMEBrusesJTopfN, and others. 2004. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci U S A101(34):12543–8.
53.
PfistererUKirkebyATorperOWoodJNelanderJDufourA, and others. 2011. Direct conversion of human fibroblasts to dopaminergic neurons. Proc Natl Acad Sci U S A108(25):10343–8.
54.
PuriMCNagyA. 2012. Concise review: embryonic stem cells versus induced pluripotent stem cells: the game is on. Stem Cells30(1):10–4.
55.
RobintonDADaleyGQ. 2012. The promise of induced pluripotent stem cells in research and therapy. Nature481(7381):295–305.
56.
RowlandBDPeeperDS. 2006. KLF4, p21 and context-dependent opposing forces in cancer. Nat Rev Cancer6(1):11–23.
57.
SahaKJaenischR. 2009. Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell5(6):584–95.
58.
Sanchez-DanesARichaud-PatinYCarballo-CarbajalIJimenez-DelgadoSCaigCMoraS, and others. 2012. Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson’s disease. EMBO Mol Med4(5):380–95.
59.
ShiYKirwanPSmithJRobinsonHPLiveseyFJ. 2012. Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses. Nat Neurosci15(3):477–86, S1.
60.
SoldnerFHockemeyerDBeardCGaoQBellGWCookEG, and others. 2009. Parkinson’s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell136(5):964–77.
61.
SonEYIchidaJKWaingerBJTomaJSRafuseVFWoolfCJ, and others. 2011. Conversion of mouse and human fibroblasts into functional spinal motor neurons. Cell Stem Cell9(3):205–18.
62.
TakahashiKTanabeKOhnukiMNaritaMIchisakaTTomodaK, and others. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell131(5):861–72.
63.
TakahashiKYamanakaS. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell126(4):663–76.
64.
ThierMWorsdorferPLakesYBGorrisRHermsSOpitzT, and others. 2012. Direct conversion of fibroblasts into stably expandable neural stem cells. Cell Stem Cell10(4):473–9.
65.
ThomsonJAItskovitz-EldorJShapiroSSWaknitzMASwiergielJJMarshallVS, and others. 1998. Embryonic stem cell lines derived from human blastocysts. Science282(5391):1145–7.
66.
VierbuchenTOstermeierAPangZPKokubuYSudhofTCWernigM. 2010. Direct conversion of fibroblasts to functional neurons by defined factors. Nature463(7284):1035–41.
67.
WatanabeKKamiyaDNishiyamaAKatayamaTNozakiSKawasakiH, and others. 2005. Directed differentiation of telencephalic precursors from embryonic stem cells. Nat Neurosci8(3):288–96.
68.
WernigMZhaoJPPruszakJHedlundEFuDSoldnerF, and others. 2008. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson’s disease. Proc Natl Acad Sci U S A105(15):5856–61.
69.
WichterleHLieberamIPorterJAJessellTM. 2002. Directed differentiation of embryonic stem cells into motor neurons. Cell110(3):385–97.
70.
WilmutISchniekeAEMcWhirJKindAJCampbellKH. 1997. Viable offspring derived from fetal and adult mammalian cells. Nature385(6619):810–3.
71.
WoltjenKMichaelIPMohseniPDesaiRMileikovskyMHamalainenR, and others. 2009. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature458(7239):766–70.
72.
XieHYeMFengRGrafT. 2004. Stepwise reprogramming of B cells into macrophages. Cell117(5):663–76.
73.
YagiTItoDOkadaYAkamatsuWNiheiYYoshizakiT, and others. 2011. Modeling familial Alzheimer’s disease with induced pluripotent stem cells. Hum Mol Genet20(23):4530–9.
74.
YingQLStavridisMGriffithsDLiMSmithA. 2003. Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat Biotechnol21(2):183–6.
75.
YuJHuKSmuga-OttoKTianSStewartRSlukvinII, and others. 2009. Human induced pluripotent stem cells free of vector and transgene sequences. Science324(5928):797–801.
76.
YuJVodyanikMASmuga-OttoKAntosiewicz-BourgetJFraneJLTianS, and others. 2007. Induced pluripotent stem cell lines derived from human somatic cells. Science318(5858):1917–20.
77.
ZhouQBrownJKanarekARajagopalJMeltonDA. 2008. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature455(7213):627–32.
78.
ZouJMaederMLMaliPPruett-MillerSMThibodeau-BegannySChouBK, and others. 2009. Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell5(1):97–110.
